Pros: The work itself is genuinely interesting, focusing on cutting-edge biotech research which is why I joined. The team I worked with was collaborative and highly skilled, making daily lab tasks productive. Being in Shanghai also provided great exposure to the broader Chinese pharmaceutical and life sciences industry.
Cons: While the research is exciting, project management can sometimes feel a bit unfocused, leading to occasional scope creep or unclear priorities. Some administrative processes were a bit slow, which occasionally impacted research timelines. More streamlined communication channels would be beneficial.
Advice to Management: Consider optimizing project management workflows and cross-departmental communication to enhance efficiency. Clearer goal setting and feedback loops would support team alignment and faster progress.
Show more
Pros: Working at Shanghai Saily Biotechnology has exposed me to cutting-edge research in the Shanghai biotech scene. The team is generally collaborative, and I've learned a lot about experimental design and data analysis. The company provides good exposure to various aspects of scientific research, making it a valuable learning experience for those starting out in the industry.
Cons: The biggest challenge here is definitely managing workload. Long hours are quite common, especially when facing project deadlines, which can impact work-life balance significantly. Opportunities for formal training or structured career development seem limited, so self-driven growth is essential.
Advice to Management: Consider implementing more structured career development programs and clearer promotion criteria to retain talent. Also, actively managing project timelines could help improve work-life balance.
Show more
Does Shanghai Silei Biotechnology offer merit increases for its R&D scientists in the biopharma industry?
Yes, Shanghai Silei Biotechnology provides merit increases for their R&D scientists in the biopharma sector based on performance reviews, typically annually.
What is the escalation process like at Shanghai Caili Biotechnology for category management issues?
In my experience at this mid-sized biotech firm in Shanghai, category management issues are usually addressed by the team lead first, and then escalated to higher management if needed. It's a fairly direct process.